147 related articles for article (PubMed ID: 12708493)
41. Lentinan mitigates therarubicin-induced myelosuppression by activating bone marrow-derived macrophages in an MAPK/NF-κB-dependent manner.
Liu Q; Dong L; Li H; Yuan J; Peng Y; Dai S
Oncol Rep; 2016 Jul; 36(1):315-23. PubMed ID: 27121155
[TBL] [Abstract][Full Text] [Related]
42. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Shishodia S; Aggarwal BB
Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
[TBL] [Abstract][Full Text] [Related]
43. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
44. Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
Schmidt CM; Wang Y; Wiesenauer C
J Gastrointest Surg; 2003 Dec; 7(8):1024-33. PubMed ID: 14675712
[TBL] [Abstract][Full Text] [Related]
45. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
Meyer-Siegler K
Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163
[TBL] [Abstract][Full Text] [Related]
46. Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B.
Deva R; Shankaranarayanan P; Ciccoli R; Nigam S
J Immunol; 2003 Sep; 171(6):3047-55. PubMed ID: 12960330
[TBL] [Abstract][Full Text] [Related]
47. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts.
Kiehntopf M; Herrmann F; Brach MA
J Exp Med; 1995 Feb; 181(2):793-8. PubMed ID: 7530764
[TBL] [Abstract][Full Text] [Related]
48. Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-κB and ERK2 activation.
Yang TC; Chang PY; Kuo TL; Lu SC
Atherosclerosis; 2017 Dec; 267():1-9. PubMed ID: 29078142
[TBL] [Abstract][Full Text] [Related]
49. Modulation by tumor necrosis factor-alpha of human astroglial cell production of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF).
Tweardy DJ; Glazer EW; Mott PL; Anderson K
J Neuroimmunol; 1991 Jun; 32(3):269-78. PubMed ID: 1709645
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle.
Pascual RM; Billington CK; Hall IP; Panettieri RA; Fish JE; Peters SP; Penn RB
Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1425-35. PubMed ID: 11704539
[TBL] [Abstract][Full Text] [Related]
51. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
52. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
Denkert C; Koch I; Berger S; Köbel M; Siegert A; Hauptmann S
Cancer Lett; 2003 May; 195(1):101-9. PubMed ID: 12767518
[TBL] [Abstract][Full Text] [Related]
53. NF-kappa B involvement in IL-1 beta-induction of GM-CSF and COX-2: inhibition by glucocorticoids does not require I-kappa B.
Adcock IM; Newton R; Barnes PJ
Biochem Soc Trans; 1997 May; 25(2):154S. PubMed ID: 9191198
[No Abstract] [Full Text] [Related]
54. Interleukin 1 and/or tumor necrosis factor-alpha synergize with granulocyte-macrophage colony-stimulating factor to enhance histamine synthesis in hematopoietic cells: role of prostaglandin E2.
Piquet-Pellorce C; Homo-Delarche F; Dy M
Eur J Immunol; 1989 Nov; 19(11):1999-2003. PubMed ID: 2689185
[TBL] [Abstract][Full Text] [Related]
55. Regulation of granulocyte colony-stimulating factor and parathyroid hormone-related protein production in lung carcinoma cell line OKa-C-1.
Uemura Y; Nakata H; Kobayashi M; Harada R; Asahi Y; Taguchi H
Jpn J Cancer Res; 2000 Sep; 91(9):911-7. PubMed ID: 11011119
[TBL] [Abstract][Full Text] [Related]
56. Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production.
Sumitani K; Kamijo R; Toyoshima T; Nakanishi Y; Takizawa K; Hatori M; Nagumo M
J Oral Pathol Med; 2001 Jan; 30(1):41-7. PubMed ID: 11140899
[TBL] [Abstract][Full Text] [Related]
57. Allergen activates peripheral blood eosinophil nuclear factor-kappaB to generate granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and interleukin-8.
Coward WR; Sagara H; Wilson SJ; Holgate ST; Church MK
Clin Exp Allergy; 2004 Jul; 34(7):1071-8. PubMed ID: 15248852
[TBL] [Abstract][Full Text] [Related]
58. Human immunodeficiency virus type 1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in neuroblastoma cells through a nuclear factor-kappaB and activating protein-1 mediated mechanism.
Alvarez S; Serramía MJ; Fresno M; Muñoz-Fernández M
J Neurochem; 2005 Aug; 94(3):850-61. PubMed ID: 16001969
[TBL] [Abstract][Full Text] [Related]
59. Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells.
Tominaga K; Higuchi K; Sasaki E; Suto R; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Kim S; Iwao H; Arakawa T
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():143-50. PubMed ID: 15298620
[TBL] [Abstract][Full Text] [Related]
60. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes.
Min SY; Hwang SY; Jung YO; Jeong J; Park SH; Cho CS; Kim HY; Kim WU
J Rheumatol; 2004 May; 31(5):875-83. PubMed ID: 15124245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
